Neurocognitive and resting-state functional MRI changes in patients with diffuse gliomas after chemoradiotherapy

Zhihua Liu,Timothy J. Mitchell,Chongliang Luo,Ki Yun Park,Joshua S. Shimony,Robert Fucetola,Eric C. Leuthardt,Stephanie M. Perkins,Abraham Z. Snyder,Tong Zhu,Jiayi Huang
DOI: https://doi.org/10.1101/2024.09.25.24314312
2024-09-27
Abstract:Background: This prospective observational study employed resting-state functional MRI (rs-fMRI) to investigate network-level disturbances associated with neurocognitive function (NCF) changes in patients with gliomas following radiation therapy (RT). Methods: Adult patients with either IDH-wildtype or IDH-mutant gliomas underwent computerized NCF testing and rs-fMRI before and 6 months after RT. NCF changes were quantified by the percent change in age-normalized composite scores from baseline (ΔNCFcomp). rs-fMRI data underwent seed-based functional connectivity (FC) analysis. Whole-brain connectivity regression analysis assessed the association between network FC changes and NCF changes, using a split-sample approach with a 26-patient training set and a 6-patient validation set, iterated 200 times. Permutation tests evaluated the significance of network selection. Results: Between September 2020 and December 2023, 43 patients were enrolled, with 32 completing both initial and follow-up evaluations. The mean ΔNCFcomp was 2.9% (SD: 13.7%), with 38% experiencing a decline. Intra-hemispheric FC remained similar between ipsilateral and contralateral hemispheres for most patients at both time points. FC changes accounted for a moderate amount of variance in NCF changes (mean R : 0.301, SD: 0.249), with intra-network FC of the Parietal Memory Network (PMN-PMN, P=0.001) and inter-network FC between the PMN and the Visual Network (PMN-VN, P=0.002) as the most significant factors. Similar findings were obtained by sensitivity analyses using only the FC data from the hemisphere contralateral to the tumor. Conclusions: Post-RT rs-fMRI changes significantly predicted NCF decline, highlighting rs-fMRI as a promising imaging biomarker for neurocognitive decline after RT.
What problem does this paper attempt to address?